Cullinan Therapeutics, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1289133,
    "name": "Cullinan Therapeutics, Inc.",
    "stock_name": "Cullinan Therapeutics, Inc.",
    "full_name": "Cullinan Therapeutics, Inc.",
    "name_url": "stocks-analysis/cullinan-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "10.58",
    "chg": 0.38,
    "chgp": "3.73%",
    "dir": 1,
    "prev_price": "10.20",
    "mcapval": "404.07",
    "mcap": "",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US2300311063",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "1.76 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cullinan-therapeutics-inc-1289133-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Cullinan Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-cullinan-therapeutics-inc-technically-bullish-or-bearish-3548169",
        "imagepath": "",
        "date": "2025-09-20 20:11:14",
        "description": "As of 8 September 2025, the technical trend for Cullinan Therapeutics, Inc. has changed from mildly bearish to bearish. The current stance is bearish with significant weakness indicated by the MACD and Bollinger Bands on both weekly and monthly time frames. The daily moving averages also confirm a bearish outlook. The RSI shows no signal on the weekly chart but is bullish on the monthly, indicating mixed signals. Dow Theory and OBV are both mildly bearish on the weekly and monthly charts.\n\nIn terms of performance, the stock has underperformed significantly compared to the S&P 500 across multiple periods, with a year-to-date return of -47.95% versus the S&P 500's 12.22%, and a one-year return of -63.20% compared to 17.14% for the index...."
      },
      {
        "title": "Cullinan Therapeutics Hits New 52-Week Low at $5.89",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cullinan-therapeutics-hits-new-52-week-low-at-589-3531571",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/CullinanTherape_priceRelatedfactors_3531571.png",
        "date": "2025-09-18 13:27:20",
        "description": "Cullinan Therapeutics, Inc. has reached a new 52-week low, reflecting a difficult year with a significant stock price decline. The company, with a market capitalization of approximately USD 404 million, is currently operating at a loss and has a price-to-book ratio indicating it is valued below its book value."
      },
      {
        "title": "Cullinan Therapeutics Hits New 52-Week Low at $6.24 Amidst Major Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cullinan-therapeutics-hits-new-52-week-low-at-624-amidst-major-decline-3525958",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/CullinanTherape_priceRelatedfactors_3525958.png",
        "date": "2025-09-17 15:23:16",
        "description": "Cullinan Therapeutics, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of approximately USD 404 million, is currently operating at a loss and shows challenging financial metrics, indicating a volatile environment in the biotechnology sector."
      },
      {
        "title": "Cullinan Therapeutics Hits New 52-Week Low at $6.32",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cullinan-therapeutics-hits-new-52-week-low-at-632-3519677",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/CullinanTherape_priceRelatedfactors_3519677.png",
        "date": "2025-09-16 11:35:11",
        "description": "Cullinan Therapeutics, Inc. has reached a new 52-week low, reflecting a significant decline from its previous high. The company, with a market capitalization of USD 404 million, is currently operating at a loss and shows a negative return on equity. Its financial structure includes a low price-to-book ratio and no dividend yield."
      }
    ],
    "total": 8,
    "sid": "1289133",
    "stock_news_url": "https://www.marketsmojo.com/news/cullinan-therapeutics-inc-1289133"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Cullinan Therapeutics, Inc. technically bullish or bearish?

2025-09-20 20:11:14

As of 8 September 2025, the technical trend for Cullinan Therapeutics, Inc. has changed from mildly bearish to bearish. The current stance is bearish with significant weakness indicated by the MACD and Bollinger Bands on both weekly and monthly time frames. The daily moving averages also confirm a bearish outlook. The RSI shows no signal on the weekly chart but is bullish on the monthly, indicating mixed signals. Dow Theory and OBV are both mildly bearish on the weekly and monthly charts. In terms of performance, the stock has underperformed significantly compared to the S&P 500 across multiple periods, with a year-to-date return of -47.95% versus the S&P 500's 12.22%, and a one-year return of -63.20% compared to 17.14% for the index....

Cullinan Therapeutics Hits New 52-Week Low at $5.89

2025-09-18 13:27:20

Cullinan Therapeutics, Inc. has reached a new 52-week low, reflecting a difficult year with a significant stock price decline. The company, with a market capitalization of approximately USD 404 million, is currently operating at a loss and has a price-to-book ratio indicating it is valued below its book value.

Cullinan Therapeutics Hits New 52-Week Low at $6.24 Amidst Major Decline

2025-09-17 15:23:16

Cullinan Therapeutics, Inc. has reached a new 52-week low, reflecting a significant decline in its stock performance over the past year. The company, with a market capitalization of approximately USD 404 million, is currently operating at a loss and shows challenging financial metrics, indicating a volatile environment in the biotechnology sector.

Cullinan Therapeutics Hits New 52-Week Low at $6.32

2025-09-16 11:35:11

Cullinan Therapeutics, Inc. has reached a new 52-week low, reflecting a significant decline from its previous high. The company, with a market capitalization of USD 404 million, is currently operating at a loss and shows a negative return on equity. Its financial structure includes a low price-to-book ratio and no dividend yield.

View All News